2023 Virus-like Particle & Nano-Particle Vaccines Conference
ExpreS2>/sup>ion scientists attend the 6th VLPNPV meeting on Virus-Like Particles, the multiprotein structures that mimic native viruses but lack the […]
Aktiespararna’s Småbolagsdagarna (Small-Cap Day)
Join CFO Keith Alexander for a live update at Aktiespararna’s Småbolagsdagarna in Stockholm. You can stream the event live or […]
2023 BIO International Convention
Meet ExpreS2ion CEO, Bent Frandsen, at the largest global biotechnology industry event. More information and registration can be found on […]
Presentation of 2023 first quarter interim results
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 first quarter interim results and answer investors’ […]
Økonomisk Ugebrev Life Science Investor Conference
ExpreS2ion CEO Bent Frandsen will present ExpreS2ion to investors and potential investors. Registration is possible via the event website
2023 American Association of Cancer Research (AACR) Annual Meeting
ExpreS2ion pre-clinical development partner University of Bologna will present “Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) […]
SWISS NORDIC BIO 2023
ExpreS2ion CFO Keith Alexander will present ExpreS2ion to investors and potential investors. Registration is possible via the Swiss Nordic Bio […]
2023 Rights Issue Q&A hosted by H.C. Andersen Capital
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2023 Rights Issue and answer investors’ questions about […]
Presentation of 2022 fourth quarter and full-year results
ExpreS2ion CEO Bent U. Frandsen and CFO Keith Alexander will discuss the 2022 fourth quarter and full-year results and answer […]
Biotech Showcase
The Biotech Showcase is being held 9-11 January at the Hilton San Francisco Union Square, in San Francisco, California, USA. […]